UNICHEMLAB · Unichem Laboratories Limited · Financials
Volume · Nov 13
1531
Avg daily vol (3M)
9364
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
22.02B
+4.3%
FY2026
Net Income
0
FY2026
Operating Cash Flow
36.4M
+151.9%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| INR | 23.69B | 22.02B | 21.11B | 17.05B | 13.43B | 12.7B | 12.35B | 12.11B |
| INR | 1.22B | 1.25B | 1.25B | 1.13B | 1.13B | 911.66M | 843.56M | 816.69M |
| INR | 311.4M | 315.9M | 210.3M | 226.61M | 173.13M | 61.05M | 51.19M | 78.47M |
| INR | 3.89B | 2.92B | 1.55B | -616.66M | -1.76B | — | — | — |
| INR | 496.9M | 395.4M | 170.7M | 88.08M | 258.65M | -110.93M | 171.55M | 119.72M |
| INR | 0 | 0 | 0 | 0 | -2.02B | 0 | 0 | 0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 571.7M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.